Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Pulmonary hypertension
- Histopathology of PAH
- Familial PAH-classical linkage
- Variable age of onset and penetrance
- Key genes in the pathogenesis of PAH
- Family A: HHT & PAH
- Pathogenesis of HHT & PAH
- Other mutations found in heritable PAH
- Differential effects of BMPR2 mutation
- Most BMPR2 carriers are classified as iPAH
- Different kinds of genetic factors for PAH
- A new locus for susceptibility to PAH identified
- Exome sequencing for disease causing variants
- Well characterised family without a mutation
- Exome seq. identified KCNK3 G203D mutation
- Variants identified in familial and idiopathic PAH
- KCNK3: details
- Mutation locations in KCNK3
- Potential role of gene mutations in PAH
- Genetic counselling for PAH (1)
- Genetic counselling for PAH (2)
- Asymptomatic relatives
- Aim of latest research in UK
- Collaborators
Topics Covered
- Histopathology of PAH
- Familial PAH: classical linkage
- Variable age of onset and penetrance
- Pathogenesis of HHT & PAH
- Key genes in the pathogenesis of PAH
- The BMPR2 mutation (classification as iPAH)
- Different kinds of genetic factors for PAH
- A locus for susceptibility to PAH
- Exome sequencing for disease causing variants
- Mutation locations in KCNK3
- Variants identified in familial and idiopathic PAH
- Potential role of gene mutations in PAH
- Genetic counselling for PAH
- Asymptomatic relatives and families without mutation
- Aim of latest research in UK
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Trembath, R.C. (2014, September 3). Molecular genetics of pulmonary arterial hypertension [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/WEWK7242.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Richard C. Trembath has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Biochemistry
Transcript
Please wait while the transcript is being prepared...
0:00
Professor Richard Trembath and
I'm going to talk to you today
about the molecular genetics of
pulmonary arterial hypertension.
0:11
Pulmonary hypertension is
defined as an elevation
of the pulmonary arterial pressure
and has a multitude of causes.
The recent classification
from an expert group
identified some of the
associated conditions that
can lead to an elevation
of the pressure
within the pulmonary
arterial circulation.
A noted important group of patients
who have no known or recognized
associated cause and
fit into the category
of heritable and idiopathic
pulmonary arterial hypertension
are the focus of this talk.
0:49
The characteristic histopathology
of pulmonary arterial hypertension
in its idiopathic
and heritable form is
one of increase in
the smooth musculature
of the pulmonary arterial
circulation, a predisposition
to formation of
intravascular thrombosis
and occlusion together with
the pathognomonic plexiform
lesions that are shown in
this illustration in panel D.
1:20
Pulmonary arterial hypertension
can and is frequently
transmitted as a familial disorder.
In this slide we show the
characteristic pattern
of inheritance with a autosomal
dominant mode of transmission--
multiple affected family members
over several generations.
But clearly the gene is acting
with reduced gene penetrance
with individuals transmitting the
disease indicated in the slide
in gray, and yet not
developing the characteristic
clinical or
histopathological features.
Though it also
indicated in the slide
is the variable age of onset--
the numbers below the individuals
indicating the age at which
clinical symptoms became apparent.
And finally, as is true
for both idiopathic disease
and when the disease is present
within multiple family members,
there is a sex bias despite the
autosomal nature of the condition
with females more
frequently affected
than males with the
ratio of 2.5 to one.